Nasdaq
$0.8055▼ 1.35%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.2MShares out 1.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
30- 5d agoAfter-hours26.10.20 06:25DEFR14AOther#●●●
iSpecimen Inc.
iSpecimen has amended the approval requirement for Proposal No. 2, the reverse stock split, from a majority of outstanding shares to a simple majority of votes cast. Consequently, the special meeting was adjourned to October 30, 2026, and broker discretionary voting is now permitted for this proposal. The board of directors will determine the final reverse stock split ratio within the range of 1:10 to 1:100.…more
$0.8055-1.35%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9After-hours26.10.10 06:15PRER14AOther
iSpecimen Inc.
iSpecimen adjourned the vote on Proposal No. 2, the reverse stock split, at its October 9, 2026, special meeting to October 30, 2026. The company amended the voting standard for this proposal to a majority of votes cast rather than a majority of outstanding shares, and confirmed that broker discretionary voting is permitted. As of the August 12, 2026 record date, there were 2,518,590 shares of common stock issued and outstanding.…more
$0.8055-1.35%vs prev closeView filingShare - 10.9After-hours26.10.10 05:308-KKey event
iSpecimen Inc.
iSpecimen held a special meeting on October 9, 2026, approving the issuance of pre-funded warrants, future convertible financing, and the acquisition of assets from Foldlab AI. The proposal for a reverse stock split (1:10 to 1:100) was adjourned until October 30, 2026, to allow for additional voting. These approvals authorize the company to proceed with significant share issuances and strategic asset acquisition.…more
$0.8055-1.35%vs prev closeView filingShare
29 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.4After-hours26.09.05 05:51#●●●#●●●
iSpecimen to Acquire Foldlab AI Assets for $4.5M
iSpecimen has entered into an agreement to acquire AI assets, including models and software, from Foldlab AI for $4.5 million. The purchase price will be settled through a combination of cash payments and the issuance of company common stock.…more
$0.8055-1.35%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 8.31After-hours26.09.01 06:27
●●●●●●●● ●●●●● ●●●●●●
iSpecimen announced that Katharyn Field will step down as CEO, with Shahin Behroyan appointed as her successor. There is no immediate information regarding significant shifts in business strategy following this leadership change.…more
$0.8055-1.35%vs prev closeShareBenzinga - 8.20After-hours26.08.21 05:10
●●●●●●●● ●●●●● ●●●●●●
iSpecimen successfully completed an international cancer research project by delivering hundreds of blood specimens within three weeks of receiving the order. While the company demonstrated its large-scale sourcing and logistics capabilities, no specific financial terms or revenue impacts were disclosed.…more
$0.8055-1.35%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report